One of the largest clinical trials focusing on long-term stroke prevention has come to this encouraging conclusion: Stenting and surgery for narrow carotid arteries, both minimally invasive procedures, are equally effective.
For doctors at
Miami Cardiac & Vascular Institute, the results from the CREST Trial, a 10-year, federally funded clinical trial, represent the latest advancement in improving the long-term health of patients with underlying risk factors for stroke. The Institute was one of the key clinical trial sites in the United States participating in the study.
And now the Institute is well underway with its participation in CREST-2, the follow-up trial which launched in December 2014.
"CREST is the most successful revascularization trial ever," says
Barry T. Katzen, MD, Founder and Chief Medical Executive of Miami Cardiac & Vascular Institute, and the site principal investigator for the clinical trials.